nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—Promazine—Tamoxifen—pancreatic cancer	0.207	1	CrCrCtD
Fluphenazine—CYP2E1—Dacarbazine—pancreatic cancer	0.0724	0.155	CbGbCtD
Fluphenazine—CYP2E1—Tamoxifen—pancreatic cancer	0.0576	0.123	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—pancreatic cancer	0.0418	0.0897	CbGbCtD
Fluphenazine—CYP1A2—Tamoxifen—pancreatic cancer	0.0333	0.0714	CbGbCtD
Fluphenazine—ABCB1—Tamoxifen—pancreatic cancer	0.0291	0.0624	CbGbCtD
Fluphenazine—CYP1A2—Erlotinib—pancreatic cancer	0.0283	0.0607	CbGbCtD
Fluphenazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0274	0.0588	CbGbCtD
Fluphenazine—ABCB1—Gemcitabine—pancreatic cancer	0.0251	0.0538	CbGbCtD
Fluphenazine—ABCB1—Erlotinib—pancreatic cancer	0.0248	0.0531	CbGbCtD
Fluphenazine—CYP1A2—Fluorouracil—pancreatic cancer	0.0245	0.0526	CbGbCtD
Fluphenazine—CYP2D6—Erlotinib—pancreatic cancer	0.0233	0.05	CbGbCtD
Fluphenazine—ABCB1—Irinotecan—pancreatic cancer	0.0224	0.0479	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—pancreatic cancer	0.0164	0.0351	CbGbCtD
Fluphenazine—ABCB1—Sunitinib—pancreatic cancer	0.0163	0.035	CbGbCtD
Fluphenazine—ABCB1—Doxorubicin—pancreatic cancer	0.0122	0.0262	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0115	0.0247	CbGbCtD
Fluphenazine—Faecaloma—Doxorubicin—pancreatic cancer	0.00161	0.0116	CcSEcCtD
Fluphenazine—Faecalith—Doxorubicin—pancreatic cancer	0.00161	0.0116	CcSEcCtD
Fluphenazine—Blood disorder—Sunitinib—pancreatic cancer	0.00155	0.0112	CcSEcCtD
Fluphenazine—Hepatocellular injury—Tamoxifen—pancreatic cancer	0.00152	0.0109	CcSEcCtD
Fluphenazine—Hepatocellular injury—Erlotinib—pancreatic cancer	0.0015	0.0108	CcSEcCtD
Fluphenazine—Pigmentation disorder—Epirubicin—pancreatic cancer	0.00149	0.0107	CcSEcCtD
Fluphenazine—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.00141	0.0101	CcSEcCtD
Fluphenazine—Pigmentation disorder—Doxorubicin—pancreatic cancer	0.00138	0.00994	CcSEcCtD
Fluphenazine—Menstruation irregular—Docetaxel—pancreatic cancer	0.00133	0.0096	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Docetaxel—pancreatic cancer	0.00133	0.0096	CcSEcCtD
Fluphenazine—Tenderness—Gemcitabine—pancreatic cancer	0.00119	0.00858	CcSEcCtD
Fluphenazine—Renal failure acute—Erlotinib—pancreatic cancer	0.00118	0.00848	CcSEcCtD
Fluphenazine—Tenderness—Fluorouracil—pancreatic cancer	0.00117	0.00844	CcSEcCtD
Fluphenazine—Leukocytosis—Fluorouracil—pancreatic cancer	0.00109	0.00784	CcSEcCtD
Fluphenazine—Eczema—Sunitinib—pancreatic cancer	0.00105	0.00754	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.00104	0.00747	CcSEcCtD
Fluphenazine—Nasal congestion—Sunitinib—pancreatic cancer	0.00103	0.00744	CcSEcCtD
Fluphenazine—Renal failure acute—Sunitinib—pancreatic cancer	0.00102	0.00734	CcSEcCtD
Fluphenazine—Dermatitis atopic—Docetaxel—pancreatic cancer	0.000998	0.00718	CcSEcCtD
Fluphenazine—Dysphagia—Tamoxifen—pancreatic cancer	0.000951	0.00684	CcSEcCtD
Fluphenazine—Dysphagia—Erlotinib—pancreatic cancer	0.000941	0.00676	CcSEcCtD
Fluphenazine—Pancytopenia—Tamoxifen—pancreatic cancer	0.000903	0.00649	CcSEcCtD
Fluphenazine—Pneumonia—Tamoxifen—pancreatic cancer	0.000853	0.00613	CcSEcCtD
Fluphenazine—Photosensitivity—Fluorouracil—pancreatic cancer	0.000846	0.00609	CcSEcCtD
Fluphenazine—Pneumonia—Erlotinib—pancreatic cancer	0.000844	0.00607	CcSEcCtD
Fluphenazine—Renal failure acute—Irinotecan—pancreatic cancer	0.000841	0.00604	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Irinotecan—pancreatic cancer	0.000822	0.00591	CcSEcCtD
Fluphenazine—Dysphagia—Sunitinib—pancreatic cancer	0.000814	0.00586	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Irinotecan—pancreatic cancer	0.000802	0.00577	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Gemcitabine—pancreatic cancer	0.000781	0.00562	CcSEcCtD
Fluphenazine—Pancytopenia—Sunitinib—pancreatic cancer	0.000773	0.00556	CcSEcCtD
Fluphenazine—Lethargy—Fluorouracil—pancreatic cancer	0.000758	0.00545	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Sunitinib—pancreatic cancer	0.000757	0.00544	CcSEcCtD
Fluphenazine—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00075	0.00539	CcSEcCtD
Fluphenazine—HTR2A—enteric nervous system—pancreatic cancer	0.000749	0.338	CbGeAlD
Fluphenazine—Hepatocellular injury—Docetaxel—pancreatic cancer	0.000739	0.00531	CcSEcCtD
Fluphenazine—Cardiac arrest—Irinotecan—pancreatic cancer	0.000738	0.00531	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Epirubicin—pancreatic cancer	0.000731	0.00526	CcSEcCtD
Fluphenazine—Pneumonia—Sunitinib—pancreatic cancer	0.00073	0.00525	CcSEcCtD
Fluphenazine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.000707	0.00508	CcSEcCtD
Fluphenazine—Seborrhoeic dermatitis—Doxorubicin—pancreatic cancer	0.000677	0.00487	CcSEcCtD
Fluphenazine—Dermatitis atopic—Epirubicin—pancreatic cancer	0.000673	0.00484	CcSEcCtD
Fluphenazine—Erythema—Tamoxifen—pancreatic cancer	0.000662	0.00476	CcSEcCtD
Fluphenazine—Erythema—Erlotinib—pancreatic cancer	0.000655	0.00471	CcSEcCtD
Fluphenazine—Dysphagia—Fluorouracil—pancreatic cancer	0.000642	0.00462	CcSEcCtD
Fluphenazine—Oedema peripheral—Sunitinib—pancreatic cancer	0.000642	0.00462	CcSEcCtD
Fluphenazine—Muscle spasms—Tamoxifen—pancreatic cancer	0.000637	0.00458	CcSEcCtD
Fluphenazine—Eosinophilia—Fluorouracil—pancreatic cancer	0.000636	0.00457	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Irinotecan—pancreatic cancer	0.000623	0.00448	CcSEcCtD
Fluphenazine—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.000623	0.00448	CcSEcCtD
Fluphenazine—Pancytopenia—Gemcitabine—pancreatic cancer	0.00062	0.00446	CcSEcCtD
Fluphenazine—Pancytopenia—Fluorouracil—pancreatic cancer	0.00061	0.00439	CcSEcCtD
Fluphenazine—Angioedema—Tamoxifen—pancreatic cancer	0.000605	0.00435	CcSEcCtD
Fluphenazine—Pneumonia—Irinotecan—pancreatic cancer	0.000601	0.00433	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Fluorouracil—pancreatic cancer	0.000597	0.00429	CcSEcCtD
Fluphenazine—Blood disorder—Epirubicin—pancreatic cancer	0.000597	0.00429	CcSEcCtD
Fluphenazine—Leukopenia—Tamoxifen—pancreatic cancer	0.000593	0.00426	CcSEcCtD
Fluphenazine—Liver injury—Epirubicin—pancreatic cancer	0.000592	0.00426	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.000586	0.00422	CcSEcCtD
Fluphenazine—Pneumonia—Gemcitabine—pancreatic cancer	0.000586	0.00421	CcSEcCtD
Fluphenazine—Pneumonia—Fluorouracil—pancreatic cancer	0.000576	0.00414	CcSEcCtD
Fluphenazine—Hypertension—Tamoxifen—pancreatic cancer	0.000572	0.00411	CcSEcCtD
Fluphenazine—Erythema—Sunitinib—pancreatic cancer	0.000567	0.00408	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.000567	0.00408	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—pancreatic cancer	0.000552	0.00397	CcSEcCtD
Fluphenazine—Dry mouth—Tamoxifen—pancreatic cancer	0.000552	0.00397	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—pancreatic cancer	0.000548	0.00394	CcSEcCtD
Fluphenazine—Lethargy—Docetaxel—pancreatic cancer	0.000547	0.00394	CcSEcCtD
Fluphenazine—Muscle spasms—Sunitinib—pancreatic cancer	0.000545	0.00392	CcSEcCtD
Fluphenazine—Agranulocytosis—Gemcitabine—pancreatic cancer	0.000544	0.00391	CcSEcCtD
Fluphenazine—Agranulocytosis—Fluorouracil—pancreatic cancer	0.000535	0.00384	CcSEcCtD
Fluphenazine—Dyskinesia—Epirubicin—pancreatic cancer	0.00053	0.00381	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.000525	0.00377	CcSEcCtD
Fluphenazine—Skin disorder—Erlotinib—pancreatic cancer	0.00052	0.00374	CcSEcCtD
Fluphenazine—Angioedema—Sunitinib—pancreatic cancer	0.000518	0.00373	CcSEcCtD
Fluphenazine—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000515	0.0037	CcSEcCtD
Fluphenazine—Leukopenia—Sunitinib—pancreatic cancer	0.000508	0.00365	CcSEcCtD
Fluphenazine—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000498	0.00358	CcSEcCtD
Fluphenazine—Abnormal dreams—Epirubicin—pancreatic cancer	0.000493	0.00354	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—pancreatic cancer	0.000491	0.00353	CcSEcCtD
Fluphenazine—Hypertension—Sunitinib—pancreatic cancer	0.00049	0.00352	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.000484	0.00348	CcSEcCtD
Fluphenazine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000482	0.00347	CcSEcCtD
Fluphenazine—Dyspnoea—Erlotinib—pancreatic cancer	0.000477	0.00343	CcSEcCtD
Fluphenazine—Dry mouth—Sunitinib—pancreatic cancer	0.000472	0.0034	CcSEcCtD
Fluphenazine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00047	0.00338	CcSEcCtD
Fluphenazine—Decreased appetite—Erlotinib—pancreatic cancer	0.000465	0.00334	CcSEcCtD
Fluphenazine—Dysphagia—Docetaxel—pancreatic cancer	0.000464	0.00333	CcSEcCtD
Fluphenazine—Constipation—Tamoxifen—pancreatic cancer	0.000462	0.00332	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000461	0.00332	CcSEcCtD
Fluphenazine—Constipation—Erlotinib—pancreatic cancer	0.000457	0.00329	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—pancreatic cancer	0.000456	0.00328	CcSEcCtD
Fluphenazine—Erythema—Gemcitabine—pancreatic cancer	0.000455	0.00327	CcSEcCtD
Fluphenazine—Skin disorder—Sunitinib—pancreatic cancer	0.00045	0.00323	CcSEcCtD
Fluphenazine—Muscle spasms—Irinotecan—pancreatic cancer	0.000449	0.00323	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000448	0.00322	CcSEcCtD
Fluphenazine—Erythema—Fluorouracil—pancreatic cancer	0.000448	0.00322	CcSEcCtD
Fluphenazine—Pancytopenia—Docetaxel—pancreatic cancer	0.00044	0.00317	CcSEcCtD
Fluphenazine—Urticaria—Tamoxifen—pancreatic cancer	0.000429	0.00309	CcSEcCtD
Fluphenazine—Body temperature increased—Erlotinib—pancreatic cancer	0.000423	0.00304	CcSEcCtD
Fluphenazine—Vision blurred—Fluorouracil—pancreatic cancer	0.000422	0.00303	CcSEcCtD
Fluphenazine—Leukopenia—Irinotecan—pancreatic cancer	0.000418	0.00301	CcSEcCtD
Fluphenazine—Pneumonia—Docetaxel—pancreatic cancer	0.000416	0.00299	CcSEcCtD
Fluphenazine—Dyspnoea—Sunitinib—pancreatic cancer	0.000413	0.00297	CcSEcCtD
Fluphenazine—Photosensitivity—Epirubicin—pancreatic cancer	0.000412	0.00296	CcSEcCtD
Fluphenazine—Leukopenia—Gemcitabine—pancreatic cancer	0.000407	0.00293	CcSEcCtD
Fluphenazine—Hypertension—Irinotecan—pancreatic cancer	0.000403	0.0029	CcSEcCtD
Fluphenazine—Eczema—Epirubicin—pancreatic cancer	0.000403	0.0029	CcSEcCtD
Fluphenazine—Decreased appetite—Sunitinib—pancreatic cancer	0.000403	0.00289	CcSEcCtD
Fluphenazine—Leukopenia—Fluorouracil—pancreatic cancer	0.000401	0.00288	CcSEcCtD
Fluphenazine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000398	0.00286	CcSEcCtD
Fluphenazine—Constipation—Sunitinib—pancreatic cancer	0.000396	0.00285	CcSEcCtD
Fluphenazine—Hypertension—Gemcitabine—pancreatic cancer	0.000393	0.00283	CcSEcCtD
Fluphenazine—Renal failure acute—Epirubicin—pancreatic cancer	0.000392	0.00282	CcSEcCtD
Fluphenazine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000386	0.00277	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.000383	0.00276	CcSEcCtD
Fluphenazine—Pruritus—Tamoxifen—pancreatic cancer	0.000382	0.00275	CcSEcCtD
Fluphenazine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000381	0.00274	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—pancreatic cancer	0.000381	0.00274	CcSEcCtD
Fluphenazine—Pruritus—Erlotinib—pancreatic cancer	0.000378	0.00272	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000374	0.00269	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—pancreatic cancer	0.000373	0.00268	CcSEcCtD
Fluphenazine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000372	0.00267	CcSEcCtD
Fluphenazine—Lethargy—Epirubicin—pancreatic cancer	0.000369	0.00266	CcSEcCtD
Fluphenazine—Body temperature increased—Sunitinib—pancreatic cancer	0.000366	0.00263	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—pancreatic cancer	0.000366	0.00263	CcSEcCtD
Fluphenazine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000365	0.00263	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—pancreatic cancer	0.000363	0.00261	CcSEcCtD
Fluphenazine—Skin disorder—Gemcitabine—pancreatic cancer	0.000361	0.0026	CcSEcCtD
Fluphenazine—Tachycardia—Fluorouracil—pancreatic cancer	0.000357	0.00256	CcSEcCtD
Fluphenazine—Hypotension—Irinotecan—pancreatic cancer	0.000356	0.00256	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000355	0.00255	CcSEcCtD
Fluphenazine—Hypotension—Gemcitabine—pancreatic cancer	0.000347	0.0025	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000346	0.00249	CcSEcCtD
Fluphenazine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000344	0.00247	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—pancreatic cancer	0.000342	0.00246	CcSEcCtD
Fluphenazine—Hypotension—Fluorouracil—pancreatic cancer	0.000341	0.00245	CcSEcCtD
Fluphenazine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000341	0.00245	CcSEcCtD
Fluphenazine—Dyspnoea—Irinotecan—pancreatic cancer	0.00034	0.00245	CcSEcCtD
Fluphenazine—Somnolence—Irinotecan—pancreatic cancer	0.000339	0.00244	CcSEcCtD
Fluphenazine—Headache—Tamoxifen—pancreatic cancer	0.000339	0.00244	CcSEcCtD
Fluphenazine—Headache—Erlotinib—pancreatic cancer	0.000335	0.00241	CcSEcCtD
Fluphenazine—Decreased appetite—Irinotecan—pancreatic cancer	0.000332	0.00238	CcSEcCtD
Fluphenazine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000331	0.00238	CcSEcCtD
Fluphenazine—Somnolence—Gemcitabine—pancreatic cancer	0.00033	0.00238	CcSEcCtD
Fluphenazine—Pruritus—Sunitinib—pancreatic cancer	0.000328	0.00236	CcSEcCtD
Fluphenazine—Constipation—Irinotecan—pancreatic cancer	0.000326	0.00235	CcSEcCtD
Fluphenazine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000326	0.00234	CcSEcCtD
Fluphenazine—Somnolence—Fluorouracil—pancreatic cancer	0.000325	0.00234	CcSEcCtD
Fluphenazine—Erythema—Docetaxel—pancreatic cancer	0.000323	0.00232	CcSEcCtD
Fluphenazine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000323	0.00232	CcSEcCtD
Fluphenazine—Nausea—Tamoxifen—pancreatic cancer	0.000321	0.00231	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000318	0.00229	CcSEcCtD
Fluphenazine—Constipation—Gemcitabine—pancreatic cancer	0.000318	0.00228	CcSEcCtD
Fluphenazine—Nausea—Erlotinib—pancreatic cancer	0.000318	0.00228	CcSEcCtD
Fluphenazine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000318	0.00228	CcSEcCtD
Fluphenazine—Asthma—Epirubicin—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Fluphenazine—Dysphagia—Epirubicin—pancreatic cancer	0.000313	0.00225	CcSEcCtD
Fluphenazine—Muscle spasms—Docetaxel—pancreatic cancer	0.000311	0.00223	CcSEcCtD
Fluphenazine—Eosinophilia—Epirubicin—pancreatic cancer	0.00031	0.00223	CcSEcCtD
Fluphenazine—Body temperature increased—Irinotecan—pancreatic cancer	0.000302	0.00217	CcSEcCtD
Fluphenazine—Pancytopenia—Epirubicin—pancreatic cancer	0.000297	0.00214	CcSEcCtD
Fluphenazine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000294	0.00211	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000291	0.00209	CcSEcCtD
Fluphenazine—Urticaria—Fluorouracil—pancreatic cancer	0.00029	0.00209	CcSEcCtD
Fluphenazine—Headache—Sunitinib—pancreatic cancer	0.00029	0.00209	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—pancreatic cancer	0.000289	0.00208	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—pancreatic cancer	0.000289	0.00208	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—pancreatic cancer	0.000289	0.00208	CcSEcCtD
Fluphenazine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000289	0.00208	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—pancreatic cancer	0.000286	0.00206	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000285	0.00205	CcSEcCtD
Fluphenazine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000281	0.00202	CcSEcCtD
Fluphenazine—Pneumonia—Epirubicin—pancreatic cancer	0.00028	0.00202	CcSEcCtD
Fluphenazine—Hypertension—Docetaxel—pancreatic cancer	0.000279	0.00201	CcSEcCtD
Fluphenazine—Drowsiness—Epirubicin—pancreatic cancer	0.000279	0.00201	CcSEcCtD
Fluphenazine—Nausea—Sunitinib—pancreatic cancer	0.000275	0.00198	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—pancreatic cancer	0.000275	0.00198	CcSEcCtD
Fluphenazine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000269	0.00194	CcSEcCtD
Fluphenazine—Dry mouth—Docetaxel—pancreatic cancer	0.000269	0.00193	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000269	0.00193	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000264	0.0019	CcSEcCtD
Fluphenazine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000264	0.0019	CcSEcCtD
Fluphenazine—Pruritus—Gemcitabine—pancreatic cancer	0.000263	0.00189	CcSEcCtD
Fluphenazine—Agranulocytosis—Epirubicin—pancreatic cancer	0.00026	0.00187	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—pancreatic cancer	0.000259	0.00187	CcSEcCtD
Fluphenazine—Pruritus—Fluorouracil—pancreatic cancer	0.000258	0.00186	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—pancreatic cancer	0.000258	0.00186	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—pancreatic cancer	0.000257	0.00185	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—pancreatic cancer	0.000256	0.00184	CcSEcCtD
Fluphenazine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000247	0.00177	CcSEcCtD
Fluphenazine—Hypotension—Docetaxel—pancreatic cancer	0.000246	0.00177	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000241	0.00173	CcSEcCtD
Fluphenazine—Headache—Irinotecan—pancreatic cancer	0.000239	0.00172	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—pancreatic cancer	0.000235	0.00169	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—pancreatic cancer	0.000234	0.00169	CcSEcCtD
Fluphenazine—Headache—Gemcitabine—pancreatic cancer	0.000233	0.00167	CcSEcCtD
Fluphenazine—Decreased appetite—Docetaxel—pancreatic cancer	0.000229	0.00165	CcSEcCtD
Fluphenazine—Headache—Fluorouracil—pancreatic cancer	0.000229	0.00165	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000228	0.00164	CcSEcCtD
Fluphenazine—Nausea—Irinotecan—pancreatic cancer	0.000227	0.00163	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—pancreatic cancer	0.000225	0.00162	CcSEcCtD
Fluphenazine—Nausea—Gemcitabine—pancreatic cancer	0.000221	0.00159	CcSEcCtD
Fluphenazine—Erythema—Epirubicin—pancreatic cancer	0.000218	0.00157	CcSEcCtD
Fluphenazine—Nausea—Fluorouracil—pancreatic cancer	0.000217	0.00156	CcSEcCtD
Fluphenazine—Muscle spasms—Epirubicin—pancreatic cancer	0.000209	0.00151	CcSEcCtD
Fluphenazine—Body temperature increased—Docetaxel—pancreatic cancer	0.000208	0.0015	CcSEcCtD
Fluphenazine—Vision blurred—Epirubicin—pancreatic cancer	0.000205	0.00148	CcSEcCtD
Fluphenazine—Erythema—Doxorubicin—pancreatic cancer	0.000202	0.00145	CcSEcCtD
Fluphenazine—Agitation—Epirubicin—pancreatic cancer	0.0002	0.00144	CcSEcCtD
Fluphenazine—Leukopenia—Epirubicin—pancreatic cancer	0.000195	0.0014	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000194	0.0014	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000194	0.00139	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—pancreatic cancer	0.00019	0.00137	CcSEcCtD
Fluphenazine—Hypertension—Epirubicin—pancreatic cancer	0.000188	0.00135	CcSEcCtD
Fluphenazine—Pruritus—Docetaxel—pancreatic cancer	0.000187	0.00134	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—pancreatic cancer	0.000185	0.00133	CcSEcCtD
Fluphenazine—Dry mouth—Epirubicin—pancreatic cancer	0.000181	0.0013	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—pancreatic cancer	0.00018	0.0013	CcSEcCtD
Fluphenazine—CALM2—gall bladder—pancreatic cancer	0.00018	0.0812	CbGeAlD
Fluphenazine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000178	0.00128	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—pancreatic cancer	0.000174	0.00125	CcSEcCtD
Fluphenazine—Tachycardia—Epirubicin—pancreatic cancer	0.000174	0.00125	CcSEcCtD
Fluphenazine—Skin disorder—Epirubicin—pancreatic cancer	0.000173	0.00124	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—pancreatic cancer	0.000168	0.00121	CcSEcCtD
Fluphenazine—Hypotension—Epirubicin—pancreatic cancer	0.000166	0.0012	CcSEcCtD
Fluphenazine—Headache—Docetaxel—pancreatic cancer	0.000165	0.00119	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000165	0.00118	CcSEcCtD
Fluphenazine—Tachycardia—Doxorubicin—pancreatic cancer	0.000161	0.00115	CcSEcCtD
Fluphenazine—Skin disorder—Doxorubicin—pancreatic cancer	0.00016	0.00115	CcSEcCtD
Fluphenazine—Dyspnoea—Epirubicin—pancreatic cancer	0.000159	0.00114	CcSEcCtD
Fluphenazine—Somnolence—Epirubicin—pancreatic cancer	0.000158	0.00114	CcSEcCtD
Fluphenazine—Nausea—Docetaxel—pancreatic cancer	0.000157	0.00113	CcSEcCtD
Fluphenazine—Decreased appetite—Epirubicin—pancreatic cancer	0.000155	0.00111	CcSEcCtD
Fluphenazine—Hypotension—Doxorubicin—pancreatic cancer	0.000154	0.00111	CcSEcCtD
Fluphenazine—Constipation—Epirubicin—pancreatic cancer	0.000152	0.00109	CcSEcCtD
Fluphenazine—CALM3—islet of Langerhans—pancreatic cancer	0.00015	0.0678	CbGeAlD
Fluphenazine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000147	0.00105	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—pancreatic cancer	0.000146	0.00105	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000143	0.00103	CcSEcCtD
Fluphenazine—Urticaria—Epirubicin—pancreatic cancer	0.000141	0.00102	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Fluphenazine—Body temperature increased—Epirubicin—pancreatic cancer	0.000141	0.00101	CcSEcCtD
Fluphenazine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000131	0.000942	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—pancreatic cancer	0.000131	0.00094	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—pancreatic cancer	0.00013	0.000935	CcSEcCtD
Fluphenazine—Pruritus—Epirubicin—pancreatic cancer	0.000126	0.000905	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000121	0.000872	CcSEcCtD
Fluphenazine—CALM2—islet of Langerhans—pancreatic cancer	0.000118	0.0532	CbGeAlD
Fluphenazine—CALM1—islet of Langerhans—pancreatic cancer	0.000118	0.053	CbGeAlD
Fluphenazine—Pruritus—Doxorubicin—pancreatic cancer	0.000116	0.000837	CcSEcCtD
Fluphenazine—Headache—Epirubicin—pancreatic cancer	0.000111	0.000801	CcSEcCtD
Fluphenazine—CALM3—pancreas—pancreatic cancer	0.000106	0.0477	CbGeAlD
Fluphenazine—Nausea—Epirubicin—pancreatic cancer	0.000106	0.00076	CcSEcCtD
Fluphenazine—Headache—Doxorubicin—pancreatic cancer	0.000103	0.000741	CcSEcCtD
Fluphenazine—Nausea—Doxorubicin—pancreatic cancer	9.77e-05	0.000703	CcSEcCtD
Fluphenazine—ADRA2A—islet of Langerhans—pancreatic cancer	8.42e-05	0.038	CbGeAlD
Fluphenazine—CALM2—pancreas—pancreatic cancer	8.3e-05	0.0374	CbGeAlD
Fluphenazine—CALM1—pancreas—pancreatic cancer	8.26e-05	0.0372	CbGeAlD
Fluphenazine—CALM2—digestive system—pancreatic cancer	7.09e-05	0.032	CbGeAlD
Fluphenazine—CALM1—digestive system—pancreatic cancer	7.06e-05	0.0318	CbGeAlD
Fluphenazine—ADRA2A—pancreas—pancreatic cancer	5.92e-05	0.0267	CbGeAlD
Fluphenazine—CYP1A2—digestive system—pancreatic cancer	5.5e-05	0.0248	CbGeAlD
Fluphenazine—HRH1—digestive system—pancreatic cancer	5.15e-05	0.0232	CbGeAlD
Fluphenazine—CYP2E1—digestive system—pancreatic cancer	4.95e-05	0.0223	CbGeAlD
Fluphenazine—ABCB1—islet of Langerhans—pancreatic cancer	4.69e-05	0.0212	CbGeAlD
Fluphenazine—HTR2A—digestive system—pancreatic cancer	4.3e-05	0.0194	CbGeAlD
Fluphenazine—CYP2D6—digestive system—pancreatic cancer	3.92e-05	0.0177	CbGeAlD
Fluphenazine—ABCB1—pancreas—pancreatic cancer	3.3e-05	0.0149	CbGeAlD
Fluphenazine—ABCB1—digestive system—pancreatic cancer	2.82e-05	0.0127	CbGeAlD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	6.42e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—pancreatic cancer	6.41e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—pancreatic cancer	6.41e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—pancreatic cancer	6.41e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	6.4e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	6.39e-06	3.44e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	6.36e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	6.36e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	6.35e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—pancreatic cancer	6.35e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PPARG—pancreatic cancer	6.35e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	6.34e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	6.32e-06	3.41e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	6.31e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.3e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—STAT3—pancreatic cancer	6.3e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—STAT3—pancreatic cancer	6.3e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	6.29e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—pancreatic cancer	6.28e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—pancreatic cancer	6.28e-06	3.39e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	6.28e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	6.27e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	6.26e-06	3.38e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	6.24e-06	3.36e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	6.21e-06	3.35e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—pancreatic cancer	6.2e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—pancreatic cancer	6.2e-06	3.34e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	6.18e-06	3.33e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	6.17e-06	3.33e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—pancreatic cancer	6.17e-06	3.33e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	6.16e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	6.14e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTEN—pancreatic cancer	6.13e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	6.13e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	6.13e-06	3.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTEN—pancreatic cancer	6.1e-06	3.29e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	6.09e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—PIK3CA—pancreatic cancer	6.09e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—pancreatic cancer	6.05e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—pancreatic cancer	6.05e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—pancreatic cancer	6.03e-06	3.25e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	6e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	5.99e-06	3.23e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	5.98e-06	3.22e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	5.95e-06	3.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—pancreatic cancer	5.92e-06	3.19e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	5.91e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—pancreatic cancer	5.9e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—pancreatic cancer	5.9e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—pancreatic cancer	5.9e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	5.89e-06	3.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.89e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—pancreatic cancer	5.89e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	5.88e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	5.86e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—pancreatic cancer	5.86e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—pancreatic cancer	5.86e-06	3.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—pancreatic cancer	5.85e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—pancreatic cancer	5.85e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.84e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—pancreatic cancer	5.84e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—pancreatic cancer	5.84e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—pancreatic cancer	5.83e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	5.79e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	5.79e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.78e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	5.78e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	5.75e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	5.75e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	5.73e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—pancreatic cancer	5.72e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—pancreatic cancer	5.72e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—pancreatic cancer	5.71e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—pancreatic cancer	5.71e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	5.69e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	5.68e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—pancreatic cancer	5.67e-06	3.06e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—pancreatic cancer	5.64e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	5.64e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—pancreatic cancer	5.63e-06	3.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	5.62e-06	3.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—pancreatic cancer	5.59e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	5.59e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	5.58e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	5.57e-06	3e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	5.57e-06	3e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—pancreatic cancer	5.57e-06	3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—pancreatic cancer	5.56e-06	3e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	5.55e-06	2.99e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	5.53e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	5.53e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	5.49e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—pancreatic cancer	5.48e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—pancreatic cancer	5.48e-06	2.96e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	5.48e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	5.48e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	5.47e-06	2.95e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	5.46e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	5.45e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—pancreatic cancer	5.45e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—pancreatic cancer	5.45e-06	2.94e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	5.43e-06	2.93e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—pancreatic cancer	5.43e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—pancreatic cancer	5.41e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—pancreatic cancer	5.41e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—pancreatic cancer	5.39e-06	2.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—pancreatic cancer	5.38e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—pancreatic cancer	5.38e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PPARG—pancreatic cancer	5.38e-06	2.9e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	5.35e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	5.32e-06	2.87e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—pancreatic cancer	5.3e-06	2.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—pancreatic cancer	5.28e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—pancreatic cancer	5.25e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—pancreatic cancer	5.25e-06	2.83e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CTNNB1—pancreatic cancer	5.23e-06	2.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	5.19e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	5.18e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	5.17e-06	2.79e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—pancreatic cancer	5.15e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—pancreatic cancer	5.13e-06	2.77e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—pancreatic cancer	5.13e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—pancreatic cancer	5.11e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—pancreatic cancer	5.11e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	5.1e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—pancreatic cancer	5.1e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	5.09e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	5.09e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	5.08e-06	2.74e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	5.07e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CTNNB1—pancreatic cancer	5.06e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CTNNB1—pancreatic cancer	5.06e-06	2.73e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	5.05e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	5.04e-06	2.72e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	5.01e-06	2.7e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	5e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.99e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	4.99e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	4.99e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	4.98e-06	2.69e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	4.98e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—pancreatic cancer	4.98e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—pancreatic cancer	4.98e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—pancreatic cancer	4.97e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—pancreatic cancer	4.97e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—pancreatic cancer	4.97e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—pancreatic cancer	4.96e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—pancreatic cancer	4.96e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—pancreatic cancer	4.93e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—pancreatic cancer	4.93e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.9e-06	2.64e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	4.85e-06	2.61e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	4.83e-06	2.6e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—pancreatic cancer	4.81e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—pancreatic cancer	4.81e-06	2.59e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	4.79e-06	2.58e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—pancreatic cancer	4.76e-06	2.57e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—pancreatic cancer	4.75e-06	2.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—pancreatic cancer	4.73e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	4.71e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	4.71e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	4.7e-06	2.54e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	4.7e-06	2.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	4.64e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	4.64e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.63e-06	2.5e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—pancreatic cancer	4.62e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	4.62e-06	2.49e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—pancreatic cancer	4.6e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—pancreatic cancer	4.6e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—pancreatic cancer	4.6e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—pancreatic cancer	4.57e-06	2.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—pancreatic cancer	4.57e-06	2.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—pancreatic cancer	4.56e-06	2.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—pancreatic cancer	4.55e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—pancreatic cancer	4.54e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	4.54e-06	2.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—pancreatic cancer	4.45e-06	2.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—pancreatic cancer	4.45e-06	2.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—pancreatic cancer	4.41e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—pancreatic cancer	4.41e-06	2.38e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	4.4e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—pancreatic cancer	4.4e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—pancreatic cancer	4.4e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—pancreatic cancer	4.39e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—pancreatic cancer	4.39e-06	2.37e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	4.35e-06	2.35e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.33e-06	2.33e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	4.33e-06	2.33e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	4.32e-06	2.33e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—pancreatic cancer	4.3e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	4.29e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	4.27e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	4.26e-06	2.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—pancreatic cancer	4.24e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	4.23e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—pancreatic cancer	4.23e-06	2.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—pancreatic cancer	4.19e-06	2.26e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	4.19e-06	2.26e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.18e-06	2.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—pancreatic cancer	4.16e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—pancreatic cancer	4.16e-06	2.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—pancreatic cancer	4.14e-06	2.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—pancreatic cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—pancreatic cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	4.1e-06	2.21e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—pancreatic cancer	4.09e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—pancreatic cancer	4.09e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	4.07e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	4.07e-06	2.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—pancreatic cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—pancreatic cancer	4.06e-06	2.19e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—pancreatic cancer	4.01e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—pancreatic cancer	4.01e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	4.01e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	4e-06	2.16e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	3.94e-06	2.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—pancreatic cancer	3.91e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—pancreatic cancer	3.85e-06	2.08e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	3.81e-06	2.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—pancreatic cancer	3.79e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—pancreatic cancer	3.79e-06	2.04e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.69e-06	1.99e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.65e-06	1.97e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	3.6e-06	1.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—pancreatic cancer	3.6e-06	1.94e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	3.54e-06	1.91e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—pancreatic cancer	3.54e-06	1.91e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	3.53e-06	1.9e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—pancreatic cancer	3.51e-06	1.89e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—pancreatic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—pancreatic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—pancreatic cancer	3.48e-06	1.87e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—pancreatic cancer	3.4e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—pancreatic cancer	3.4e-06	1.83e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—pancreatic cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—pancreatic cancer	3.36e-06	1.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—pancreatic cancer	3.33e-06	1.79e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.26e-06	1.76e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.22e-06	1.74e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—pancreatic cancer	3.22e-06	1.73e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—pancreatic cancer	3.22e-06	1.73e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.07e-06	1.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—pancreatic cancer	2.94e-06	1.58e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—pancreatic cancer	2.84e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—pancreatic cancer	2.84e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—pancreatic cancer	2.66e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.6e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.51e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—pancreatic cancer	2.13e-06	1.15e-05	CbGpPWpGaD
